SETBP1 and juvenile myelomonocytic leukemia: Recently, the plating of cryopreserved samples from serial time-points during follow-up of a JMML relapsed patient demonstrated that the number of cells that were heterozygous or homozygous for the SETBP1 mutation increased at each time-point despite intensive treatment, suggesting a resistance to traditional cytotoxic therapy [85].